Remove Networking Remove Pharmaceutical manufacturing Remove Sales
article thumbnail

How to Transition From Nursing to Medical Sales

MedReps

Nurses seemingly have a leg up when it comes to branching into medical sales. After all, medical sales seem like a very different animal from nursing. One involves helping patients, while the other requires you to meet sales quotas. One involves helping patients, while the other requires you to meet sales quotas.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

The LSIMF was announced within an overall investment of £354 million for life sciences manufacturing, said MMIP, which added it will be “important to understand how and when the remaining £294 million will be allocated.” ” Image from the Association of the British Pharmaceutical Industry (ABPI).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guaranteeing resilience in vaccine manufacturing

European Pharmaceutical Review

When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”

article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

In response to the draft pandemic treaty text , the People’s Vaccine, a coalition of organisations and networks that is campaigning to make a vaccine available free of charge to everyone, called for IP to be waived for future products developed against pandemics.

article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52